CONTINUE TO SITE
OR WAIT 15 SECS
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive a
SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expand
FibroGen, Inc. has announced the sale of its China subsidiary to AstraZeneca for approximately $160 million. U
Taiwan-based Formosa Group Executive Committee member and Chairman Sandy Wang, who leads the group's bio and e
Infinitus (China) Company has secured approval for its Sino-British Joint Laboratory on Health and Ageing proj
In a breakthrough for the advanced study of gut health, scientists at the National University of Singapore (NU
Thailand's Chulalongkorn University has introduced the Exoskeleton Wheelchair, an innovative ro
ZEISS Medical Technology has announced that the National Medical Products Administration (NMPA) in China&
Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participat
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (C
Mitigating PATENT CLIFF Fallout
Monoclonal antibodies (mAbs) represent a $279.8 billion market, projected to reach $804 billion by 2033, according to a report from Dimension Market Research. With patents for many of these valuable drugs set to expire in the coming years, the industry faces significant challenges. In this story, we examine 11 blockbuster mAbs whose patents will expire between 2025 and 2030. These expirations, affecting some of pharma's biggest players, will have a major impact on the market and their revenue streams.
ISPOR 2025
ISPOR
info@ispor.org https://www.ispor.org/conferences-education/event/2025/05/13/default-calendar/ispor-2025Montreal
Cowen Health Care Conference 2025 Boston
TD Cowen
skpharmteco@skpt.com https://www.skpharmteco.com/contact-us/Boston
Lab of the Future USA 2025
Open Pharma Research Ltd
admin@openpharmaresearch.com https://www.lab-of-the-future.com/Boston USA
